Skip to Content

Clonicel Approval Status

FDA Approved: No
Brand name: Clonicel
Generic name: clonidine
Company: Sciele Pharma, Inc. and Addrenex Pharmaceuticals
Treatment for: ADHD

Clonicel is a modified-release clonidine formulation in development to treat attention deficit hyperactivity disorder (ADHD).

Development Status and FDA Approval Process for Clonicel

DateArticle
Oct  2, 2009Sciele Pharma and Addrenex Announce Submission of sNDA to FDA for Clonicel to Treat ADHD

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide